18194-24-6

18194-24-6 is a lipid of Glycerophospholipids (GP) class. 18194-24-6 is associated with abnormalities such as Cerebrovascular accident, Renal tubular disorder, Atherosclerosis, Hyperlipoproteinemia Type III and Lipid Metabolism Disorders. The involved functions are known as Process, protein folding, Catalyst, Biochemical Pathway and Fold in Medical Device Material. 18194-24-6 often locates in Tissue membrane, Membrane, periplasm, vesicle membrane and outer membrane. The associated genes with 18194-24-6 are Integral Membrane Proteins, Protein Structure, RTN4 gene, RTN4R gene and Protein, Organized by Structure. The related lipids are Micelles, dimyristoylphosphatidylglycerol, 1,2-dihexadecyl-sn-glycero-3-phosphocholine, Unilamellar Vesicles and cholesteryl oleate. The related experimental models are Mouse Model, Arthritis, Adjuvant-Induced, Disease model and Xenograft Model.

Cross Reference

Introduction

To understand associated biological information of 18194-24-6, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 18194-24-6?

18194-24-6 is suspected in Atherosclerosis, Cardiovascular Diseases, Dehydration, Abnormal shape, Renal tubular disorder, Hyperlipoproteinemia Type III and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 18194-24-6

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Lung Neoplasms D008175 171 associated lipids
Adenocarcinoma D000230 166 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hemolysis D006461 131 associated lipids
Arteriosclerosis D001161 86 associated lipids
Alzheimer Disease D000544 76 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Neuroblastoma D009447 66 associated lipids
Osteosarcoma D012516 50 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
HIV Infections D015658 20 associated lipids
Carcinoma D002277 18 associated lipids
Mycoses D009181 18 associated lipids
Hyperlipoproteinemias D006951 15 associated lipids
Lymphoma, Large B-Cell, Diffuse D016403 13 associated lipids
Colorectal Neoplasms D015179 10 associated lipids
Tangier Disease D013631 8 associated lipids
Cholangiocarcinoma D018281 7 associated lipids
Blastomycosis D001759 5 associated lipids
Anemia, Hemolytic, Congenital D000745 5 associated lipids
Lymphoma, Primary Effusion D054685 2 associated lipids
Per page 10 20 50 | Total 22

PubChem Associated disorders and diseases

What pathways are associated with 18194-24-6

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 18194-24-6?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 18194-24-6?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 18194-24-6?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 18194-24-6?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 18194-24-6?

Mouse Model

Mouse Model are used in the study 'Association of a model class A (apolipoprotein) amphipathic alpha helical peptide with lipid: high resolution NMR studies of peptide.lipid discoidal complexes.' (Mishra VK et al., 2006).

Arthritis, Adjuvant-Induced

Arthritis, Adjuvant-Induced are used in the study 'T cell antigen receptor peptide-lipid membrane interactions using surface plasmon resonance.' (Bender V et al., 2004).

Disease model

Disease model are used in the study 'Kupffer cells do not play a role in governing the efficacy of liposomal mitoxantrone used to treat a tumor model designed to assess drug delivery to liver.' (Lim HJ et al., 2000).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with 18194-24-6

Download all related citations
Per page 10 20 50 100 | Total 3218
Authors Title Published Journal PubMed Link
Fisher CA and Ryan RO Lipid binding-induced conformational changes in the N-terminal domain of human apolipoprotein E. 1999 J. Lipid Res. pmid:9869654
Gogonea V et al. The low-resolution structure of nHDL reconstituted with DMPC with and without cholesterol reveals a mechanism for particle expansion. 2013 J. Lipid Res. pmid:23349207
McGuire KA et al. High yield overexpression and characterization of human recombinant proapolipoprotein A-I. 1996 J. Lipid Res. pmid:8827524
Blanchette CD et al. Quantifying size distributions of nanolipoprotein particles with single-particle analysis and molecular dynamic simulations. 2008 J. Lipid Res. pmid:18403317
Li QT and Sawyer WH Effect of unesterified cholesterol on the compartmentation of a fluorescent cholesteryl ester in a lipoprotein-like lipid microemulsion. 1992 J. Lipid Res. pmid:1527474
Dong LM et al. The carboxyl terminus in apolipoprotein E2 and the seven amino acid repeat in apolipoprotein E-Leiden: role in receptor-binding activity. 1998 J. Lipid Res. pmid:9643348
Daum U et al. Multiple dysfunctions of two apolipoprotein A-I variants, apoA-I(R160L)Oslo and apoA-I(P165R), that are associated with hypoalphalipoproteinemia in heterozygous carriers. 1999 J. Lipid Res. pmid:10064737
Walsh MT and Atkinson D Physical properties of apoprotein B in mixed micelles with sodium deoxycholate and in a vesicle with dimyristoyl phosphatidylcholine. 1986 J. Lipid Res. pmid:3734628
MacPhee CE et al. Interaction of lipoprotein lipase with homogeneous lipid emulsions. 1997 J. Lipid Res. pmid:9300787
Gol'danskii VI et al. Free radical label: new approach to the study of super-slow molecular dynamics of lipid systems. 1981 J. Lipid Res. pmid:6260881
Kolusheva S et al. Biomimetic lipid/polymer colorimetric membranes: molecular and cooperative properties. 2003 J. Lipid Res. pmid:12518024
Meers PR and Feigenson GW Use of 31PNMR spectroscopy to follow the time course of phosphatidylcholine chemical synthesis. 1985 J. Lipid Res. pmid:3839831
DeLozier JA et al. Vesicle-binding properties of wild-type and cysteine mutant forms of alpha(1) domain of apolipoprotein B. 2001 J. Lipid Res. pmid:11254752
Jian B et al. Modification of the cholesterol efflux properties of human serum by enrichment with phospholipid. 1997 J. Lipid Res. pmid:9144088
Kateifides AK et al. Alteration of negatively charged residues in the 89 to 99 domain of apoA-I affects lipid homeostasis and maturation of HDL. 2011 J. Lipid Res. pmid:21504968
Barrow DJ et al. Mechanistic studies on percutaneous penetration enhancement by N-(4-halobenzoyl)-S,S-dimethyliminosulfuranes. 2005 J. Lipid Res. pmid:16061953
Liu H et al. Characterization of the lipid-binding properties and lipoprotein lipase inhibition of a novel apolipoprotein C-III variant Ala23Thr. 2000 J. Lipid Res. pmid:11060345
Dong J et al. Human apolipoprotein E7:lysine mutations in the carboxy-terminal domain are directly responsible for preferential binding to very low density lipoproteins. 2000 J. Lipid Res. pmid:11060347
Hajj Hassan H et al. Structural modification of plasma HDL by phospholipids promotes efficient ABCA1-mediated cholesterol release. 2005 J. Lipid Res. pmid:15654121
Cho KH et al. Role of individual amino acids of apolipoprotein A-I in the activation of lecithin:cholesterol acyltransferase and in HDL rearrangements. 2001 J. Lipid Res. pmid:11254750
Lund-Katz S et al. Effects of polymorphism on the microenvironment of the LDL receptor-binding region of human apoE. 2001 J. Lipid Res. pmid:11369796
Wang YT et al. Dimyristoylphosphotidylcholine induces conformational changes in apoB that lowers lipoprotein(a). 2009 J. Lipid Res. pmid:19098283
Butikofer P et al. Erythrocyte phospholipid organization and vesiculation in hereditary high red cell membrane phosphatidylcholine hemolytic anemia. 1989 J. Lab. Clin. Med. pmid:2926237
Pezeshk A et al. Partitional and motional properties of a spin-labeled daunomycin in lipid bilayers. An ESR study. 1992 J. Inorg. Biochem. pmid:1326024
Suwalsky M et al. Structural effects of Zn(2+) on cell membranes and molecular models. 2009 J. Inorg. Biochem. pmid:19327840
al-Baker S et al. Synthesis and biological studies of new lipid-soluble cisplatin analogues entrapped in liposomes. 1992 J. Inorg. Biochem. pmid:1431876
Suwalsky M et al. Mn2+ exerts stronger structural effects than the Mn-citrate complex on the human erythrocyte membrane and molecular models. 2010 J. Inorg. Biochem. pmid:19880186
Pezeshk A et al. Orientational and motional properties of copper (II) complexes of dibenzotetraaza [14]annulenes in lipid bilayers: an ESR study. 1991 J. Inorg. Biochem. pmid:1665172
Suwalsky M et al. Interactions of Al(acac)3 with cell membranes and model phospholipid bilayers. 1999 J. Inorg. Biochem. pmid:10499289
Subczynski WK et al. Effects of probucol on phase transition and fluidity of phosphatidylcholine membranes: a spin label study. 1994 J. Inorg. Biochem. pmid:8046434
Suwalsky M et al. HgCl2 disrupts the structure of the human erythrocyte membrane and model phospholipid bilayers. 2000 J. Inorg. Biochem. pmid:11065190
Suwalsky M et al. Structural effects of titanium citrate on the human erythrocyte membrane. 2005 J. Inorg. Biochem. pmid:15708797
Lopez-Berestein G et al. Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B. 1983 J. Infect. Dis. pmid:6842027
Yamamoto KI Proteolysis of the C5b-7 complex: cleavage of the C5b and C6 subunits and its effect on the interaction of the complex with phospholipid bilayers. 1980 J. Immunol. pmid:6997387
Mold C and Gewurz H Inhibitory effect of C-reactive protein on alternative C pathway activation by liposomes and Streptococcus pneumoniae. 1981 J. Immunol. pmid:6913608
Whitten MM et al. A novel role for an insect apolipoprotein (apolipophorin III) in beta-1,3-glucan pattern recognition and cellular encapsulation reactions. 2004 J. Immunol. pmid:14764684
Podack ER et al. Membrane attach complex of complement (MAC): three-dimensional analysis of MAC-phospholipid vesicle recombinants. 1982 J. Immunol. pmid:6174630
Strejan GH et al. Naturally occurring antibodies to liposomes. II. Specificity and electrophoretic pattern of rabbit antibodies reacting with sphingomyelin-containing liposomes. 1981 J. Immunol. pmid:6787120
Ho RJ and Huang L Interactions of antigen-sensitized liposomes with immobilized antibody: a homogeneous solid-phase immunoliposome assay. 1985 J. Immunol. pmid:3886794
Mold C et al. Interaction of C-reactive protein with liposomes. III. Membrane requirements for binding. 1981 J. Immunol. pmid:7462634
Wang Q et al. In-vivo assessment of a novel polymer (SIBS) trileaflet heart valve. 2010 J. Heart Valve Dis. pmid:20845899
Concha MI et al. Undetectable apolipoprotein A-I gene expression suggests an unusual mechanism of dietary lipid mobilisation in the intestine of Cyprinus carpio. 2005 J. Exp. Biol. pmid:15781899
Matt U et al. WAVE1 mediates suppression of phagocytosis by phospholipid-derived DAMPs. 2013 J. Clin. Invest. pmid:23934128
Suzuki M et al. Targeting ceramide synthase 6-dependent metastasis-prone phenotype in lung cancer cells. 2016 J. Clin. Invest. pmid:26650179
Azzam DJ et al. High-performance liquid chromatography method for quantifying sphingomyelin in rat brain. 2007 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:17901003
Weitz M et al. Quantitative composition and characterization of the proteins in membrane vesicles released from erythrocytes by dimyristoylphosphatidylcholine. A membrane system without cytoskeleton. 1982 J. Cell. Biochem. pmid:6184380
Brechling A et al. Structural organization of DMPC lipid layers on chemically micropatterned self-assembled monolayers as biomimetic systems. 2004 J. Biotechnol. pmid:15288947
Morita S et al. Effect of saturation in phospholipid/fatty acid monolayers on interaction with amyloid β peptide. 2018 J. Biosci. Bioeng. pmid:29175122
Garnier N et al. Molecular dynamics simulations of the transmembrane domain of the oncogenic ErbB2 receptor dimer in a DMPC bilayer. 2003 J. Biomol. Struct. Dyn. pmid:12956604
Wong TC and Kamath S Molecular dynamics simulations of adrenocorticotropin (1-24) peptide in a solvated dodecylphosphocholine (DPC) micelle and in a dimyistoylphosphatidylcholine (DMPC) bilayer. 2002 J. Biomol. Struct. Dyn. pmid:12144351